Academic Journal
Cryptococcus gattii complex infections in southern Brazil: Epidemiology, clinical features, management, and outcomes from a 33-year cohort.
| Τίτλος: | Cryptococcus gattii complex infections in southern Brazil: Epidemiology, clinical features, management, and outcomes from a 33-year cohort. |
|---|---|
| Συγγραφείς: | Carneiro BH; Hospital de Clínicas, Federal University of Paraná, Curitiba 80060-900, Brazil.; Internal Medicine Department-Internal Medicine and Health Sciences Postgraduate Program, Federal University of Paraná, Curitiba 80060-240, Brazil., Raimundo Cognialli RC; Hospital de Clínicas, Federal University of Paraná, Curitiba 80060-900, Brazil.; Basic Pathology Department-Microbiology, Parasitology and Pathology Postgraduate Program, Federal University of Paraná, Curitiba 81530-000, Brazil., Breda GL; Hospital de Clínicas, Federal University of Paraná, Curitiba 80060-900, Brazil.; Internal Medicine Department-Internal Medicine and Health Sciences Postgraduate Program, Federal University of Paraná, Curitiba 80060-240, Brazil., França JCB; Hospital de Clínicas, Federal University of Paraná, Curitiba 80060-900, Brazil., Ducroquet MA; Hospital de Clínicas, Federal University of Paraná, Curitiba 80060-900, Brazil., Muro MD; Hospital de Clínicas, Federal University of Paraná, Curitiba 80060-900, Brazil., Queiroz-Telles F; Hospital de Clínicas, Federal University of Paraná, Curitiba 80060-900, Brazil.; Internal Medicine Department-Internal Medicine and Health Sciences Postgraduate Program, Federal University of Paraná, Curitiba 80060-240, Brazil. |
| Πηγή: | Medical mycology [Med Mycol] 2026 Jul 01; Vol. 64 (7). |
| Τύπος έκδοσης: | Journal Article; Observational Study |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9815835 Publication Model: Print Cited Medium: Internet ISSN: 1460-2709 (Electronic) Linking ISSN: 13693786 NLM ISO Abbreviation: Med Mycol Subsets: MEDLINE |
| Imprint Name(s): | Publication: 2014- : Oxford : Oxford University Press Original Publication: Oxford : Blackwell Science, c1998- |
| Ιατρικοί όροι (MeSH): | Cryptococcus gattii*/isolation & purification , Cryptococcosis*/epidemiology , Cryptococcosis*/drug therapy, Brazil/epidemiology ; Antifungal Agents/therapeutic use ; Amphotericin B/therapeutic use ; Fluconazole/therapeutic use ; Deoxycholic Acid/therapeutic use ; Humans ; Male ; Middle Aged ; Female ; Adult ; Aged ; Treatment Outcome ; Drug Combinations ; Young Adult ; Cohort Studies |
| Περίληψη: | Cryptococcus gattii complex has emerged as an important cause of invasive fungal disease in both immunocompetent and immunocompromised hosts, yet robust clinical and epidemiological data remain limited, particularly in Latin America. An observational study was conducted to describe and analyze the clinical characteristics and outcomes of all proven and probable cases of C. gattii complex infection managed at a tertiary referral center in southern Brazil from 1992 to 2025. A total of 39 cases were identified. The median age was 54 years, and 61.5% were male. Most patients (61.5%) were considered immunocompetent, although comorbidities were common. Headache (61.5%), altered mental status (33.3%), and fever (30.8%) were the most frequent symptoms overall. Pulmonary disease was the predominant clinical form (76.9%), but meningitis/meningoencephalitis was also common (69.2%). Nearly half (46.2%) had both pulmonary and neurological disease. Cryptococcomas were frequent (76.9%); the majority were managed without surgical intervention. Severe impairment of consciousness at presentation and cerebrospinal fluid protein levels above 92.15 mg/dl were significantly associated with mortality. Amphotericin B deoxycholate plus fluconazole was the most prescribed induction regimen, with a median duration of 3 weeks. The overall mortality was 20.5%. Immune reconstitution inflammatory syndrome occurred only among patients with cryptococcomas and was managed with glucocorticoids in most cases. The performance of the cryptococcal antigen (CrAg) test was excellent in both neurological and pulmonary diseases. This study highlights the clinical spectrum of C. gattii complex infection and supports the potential utility of shorter induction regimens (< 4 weeks), as well as the role of CrAg as a valuable diagnostic tool. (© The Author(s) 2026. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site-for further information please contact journals.permissions@oup.com.) |
| Grant Information: | 71396723.9.0000.0096 Hospital de Clínicas Federal University of Paraná Ethics Committee |
| Contributed Indexing: | Keywords: Cryptococcus gattii; Brazil; clinical; cohort; cryptococcoma; cryptococcosis; epidemiology; outcomes Local Abstract: [plain-language-summary] The Cryptococcus gattii complex comprises fungi capable of causing lung and brain infections even in healthy people. In this Brazilian research, clinical features were studied. Headache was the most common symptom, and mortality reached 20%. The results offer important insights for clinical management. |
| Substance Nomenclature: | 0 (Antifungal Agents) 7XU7A7DROE (Amphotericin B) 8VZV102JFY (Fluconazole) 87687-70-5 (amphotericin B, deoxycholate drug combination) 005990WHZZ (Deoxycholic Acid) 0 (Drug Combinations) |
| Entry Date(s): | Date Created: 20260630 Date Completed: 20260717 Latest Revision: 20260717 |
| Update Code: | 20260718 |
| DOI: | 10.1093/mmy/myag068 |
| PMID: | 42377913 |
| Βάση Δεδομένων: | MEDLINE |
| FullText | Links: – Type: other Url: https://resolver.ebsco.com:443/public/rma-ftfapi/ejs/direct?AccessToken=498987E52BBE5ED90052&Show=Object Text: Availability: 0 |
|---|---|
| Header | DbId: cmedm DbLabel: MEDLINE An: 42377913 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Cryptococcus gattii complex infections in southern Brazil: Epidemiology, clinical features, management, and outcomes from a 33-year cohort. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Carneiro+BH%22">Carneiro BH</searchLink>; Hospital de Clínicas, Federal University of Paraná, Curitiba 80060-900, Brazil.; Internal Medicine Department-Internal Medicine and Health Sciences Postgraduate Program, Federal University of Paraná, Curitiba 80060-240, Brazil.<br /><searchLink fieldCode="AU" term="%22Raimundo+Cognialli+RC%22">Raimundo Cognialli RC</searchLink>; Hospital de Clínicas, Federal University of Paraná, Curitiba 80060-900, Brazil.; Basic Pathology Department-Microbiology, Parasitology and Pathology Postgraduate Program, Federal University of Paraná, Curitiba 81530-000, Brazil.<br /><searchLink fieldCode="AU" term="%22Breda+GL%22">Breda GL</searchLink>; Hospital de Clínicas, Federal University of Paraná, Curitiba 80060-900, Brazil.; Internal Medicine Department-Internal Medicine and Health Sciences Postgraduate Program, Federal University of Paraná, Curitiba 80060-240, Brazil.<br /><searchLink fieldCode="AU" term="%22França+JCB%22">França JCB</searchLink>; Hospital de Clínicas, Federal University of Paraná, Curitiba 80060-900, Brazil.<br /><searchLink fieldCode="AU" term="%22Ducroquet+MA%22">Ducroquet MA</searchLink>; Hospital de Clínicas, Federal University of Paraná, Curitiba 80060-900, Brazil.<br /><searchLink fieldCode="AU" term="%22Muro+MD%22">Muro MD</searchLink>; Hospital de Clínicas, Federal University of Paraná, Curitiba 80060-900, Brazil.<br /><searchLink fieldCode="AU" term="%22Queiroz-Telles+F%22">Queiroz-Telles F</searchLink>; Hospital de Clínicas, Federal University of Paraná, Curitiba 80060-900, Brazil.; Internal Medicine Department-Internal Medicine and Health Sciences Postgraduate Program, Federal University of Paraná, Curitiba 80060-240, Brazil. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229815835%22">Medical mycology</searchLink> [Med Mycol] 2026 Jul 01; Vol. 64 (7). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Observational Study – Name: Language Label: Language Group: Lang Data: English – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9815835 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1460-2709 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2213693786%22">13693786 </searchLink><i>NLM ISO Abbreviation: </i>Med Mycol <i>Subsets: </i>MEDLINE – Name: PublisherInfo Label: Imprint Name(s) Group: PubInfo Data: <i>Publication</i>: 2014- : Oxford : Oxford University Press<br /><i>Original Publication</i>: Oxford : Blackwell Science, c1998- – Name: SubjectMESH Label: MeSH Terms Group: Su Data: <searchLink fieldCode="MM" term="%22Cryptococcus+gattii%22">Cryptococcus gattii*</searchLink>/<searchLink fieldCode="MM" term="%22Cryptococcus+gattii+isolation+%26+purification%22">isolation & purification</searchLink> <br /><searchLink fieldCode="MM" term="%22Cryptococcosis%22">Cryptococcosis*</searchLink>/<searchLink fieldCode="MM" term="%22Cryptococcosis+epidemiology%22">epidemiology</searchLink> <br /><searchLink fieldCode="MM" term="%22Cryptococcosis%22">Cryptococcosis*</searchLink>/<searchLink fieldCode="MM" term="%22Cryptococcosis+drug+therapy%22">drug therapy</searchLink><br /><searchLink fieldCode="MH" term="%22Brazil%22">Brazil</searchLink>/<searchLink fieldCode="MH" term="%22Brazil+epidemiology%22">epidemiology</searchLink> ; <searchLink fieldCode="MH" term="%22Antifungal+Agents%22">Antifungal Agents</searchLink>/<searchLink fieldCode="MH" term="%22Antifungal+Agents+therapeutic+use%22">therapeutic use</searchLink> ; <searchLink fieldCode="MH" term="%22Amphotericin+B%22">Amphotericin B</searchLink>/<searchLink fieldCode="MH" term="%22Amphotericin+B+therapeutic+use%22">therapeutic use</searchLink> ; <searchLink fieldCode="MH" term="%22Fluconazole%22">Fluconazole</searchLink>/<searchLink fieldCode="MH" term="%22Fluconazole+therapeutic+use%22">therapeutic use</searchLink> ; <searchLink fieldCode="MH" term="%22Deoxycholic+Acid%22">Deoxycholic Acid</searchLink>/<searchLink fieldCode="MH" term="%22Deoxycholic+Acid+therapeutic+use%22">therapeutic use</searchLink> ; <searchLink fieldCode="MH" term="%22Humans%22">Humans</searchLink> ; <searchLink fieldCode="MH" term="%22Male%22">Male</searchLink> ; <searchLink fieldCode="MH" term="%22Middle+Aged%22">Middle Aged</searchLink> ; <searchLink fieldCode="MH" term="%22Female%22">Female</searchLink> ; <searchLink fieldCode="MH" term="%22Adult%22">Adult</searchLink> ; <searchLink fieldCode="MH" term="%22Aged%22">Aged</searchLink> ; <searchLink fieldCode="MH" term="%22Treatment+Outcome%22">Treatment Outcome</searchLink> ; <searchLink fieldCode="MH" term="%22Drug+Combinations%22">Drug Combinations</searchLink> ; <searchLink fieldCode="MH" term="%22Young+Adult%22">Young Adult</searchLink> ; <searchLink fieldCode="MH" term="%22Cohort+Studies%22">Cohort Studies</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Cryptococcus gattii complex has emerged as an important cause of invasive fungal disease in both immunocompetent and immunocompromised hosts, yet robust clinical and epidemiological data remain limited, particularly in Latin America. An observational study was conducted to describe and analyze the clinical characteristics and outcomes of all proven and probable cases of C. gattii complex infection managed at a tertiary referral center in southern Brazil from 1992 to 2025. A total of 39 cases were identified. The median age was 54 years, and 61.5% were male. Most patients (61.5%) were considered immunocompetent, although comorbidities were common. Headache (61.5%), altered mental status (33.3%), and fever (30.8%) were the most frequent symptoms overall. Pulmonary disease was the predominant clinical form (76.9%), but meningitis/meningoencephalitis was also common (69.2%). Nearly half (46.2%) had both pulmonary and neurological disease. Cryptococcomas were frequent (76.9%); the majority were managed without surgical intervention. Severe impairment of consciousness at presentation and cerebrospinal fluid protein levels above 92.15 mg/dl were significantly associated with mortality. Amphotericin B deoxycholate plus fluconazole was the most prescribed induction regimen, with a median duration of 3 weeks. The overall mortality was 20.5%. Immune reconstitution inflammatory syndrome occurred only among patients with cryptococcomas and was managed with glucocorticoids in most cases. The performance of the cryptococcal antigen (CrAg) test was excellent in both neurological and pulmonary diseases. This study highlights the clinical spectrum of C. gattii complex infection and supports the potential utility of shorter induction regimens (&lt; 4 weeks), as well as the role of CrAg as a valuable diagnostic tool.<br /> (© The Author(s) 2026. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site-for further information please contact journals.permissions@oup.com.) – Name: GrantInfo Label: Grant Information Group: Grant Data: 71396723.9.0000.0096 Hospital de Clínicas Federal University of Paraná Ethics Committee – Name: SubjectMinor Label: Contributed Indexing Group: Data: <i>Keywords: </i>Cryptococcus gattii; Brazil; clinical; cohort; cryptococcoma; cryptococcosis; epidemiology; outcomes<br /><i>Local Abstract: </i>[plain-language-summary] The Cryptococcus gattii complex comprises fungi capable of causing lung and brain infections even in healthy people. In this Brazilian research, clinical features were studied. Headache was the most common symptom, and mortality reached 20%. The results offer important insights for clinical management. – Name: NumberCAS Label: Substance Nomenclature Group: ID Data: 0 (Antifungal Agents)<br />7XU7A7DROE (Amphotericin B)<br />8VZV102JFY (Fluconazole)<br />87687-70-5 (amphotericin B, deoxycholate drug combination)<br />005990WHZZ (Deoxycholic Acid)<br />0 (Drug Combinations) – Name: DateEntry Label: Entry Date(s) Group: Date Data: <i>Date Created: </i>20260630 <i>Date Completed: </i>20260717 <i>Latest Revision: </i>20260717 – Name: DateUpdate Label: Update Code Group: Date Data: 20260718 – Name: DOI Label: DOI Group: ID Data: 10.1093/mmy/myag068 – Name: AN Label: PMID Group: ID Data: 42377913 |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cmedm&AN=42377913 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/mmy/myag068 Languages: – Code: eng Text: English Subjects: – SubjectFull: Brazil epidemiology Type: general – SubjectFull: Antifungal Agents therapeutic use Type: general – SubjectFull: Amphotericin B therapeutic use Type: general – SubjectFull: Fluconazole therapeutic use Type: general – SubjectFull: Deoxycholic Acid therapeutic use Type: general – SubjectFull: Humans Type: general – SubjectFull: Male Type: general – SubjectFull: Middle Aged Type: general – SubjectFull: Female Type: general – SubjectFull: Adult Type: general – SubjectFull: Aged Type: general – SubjectFull: Treatment Outcome Type: general – SubjectFull: Drug Combinations Type: general – SubjectFull: Young Adult Type: general – SubjectFull: Cohort Studies Type: general – SubjectFull: Cryptococcus gattii isolation & purification Type: general – SubjectFull: Cryptococcosis epidemiology Type: general – SubjectFull: Cryptococcosis drug therapy Type: general Titles: – TitleFull: Cryptococcus gattii complex infections in southern Brazil: Epidemiology, clinical features, management, and outcomes from a 33-year cohort. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Carneiro BH – PersonEntity: Name: NameFull: Raimundo Cognialli RC – PersonEntity: Name: NameFull: Breda GL – PersonEntity: Name: NameFull: França JCB – PersonEntity: Name: NameFull: Ducroquet MA – PersonEntity: Name: NameFull: Muro MD – PersonEntity: Name: NameFull: Queiroz-Telles F IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2026 Jul 01 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1460-2709 Numbering: – Type: volume Value: 64 – Type: issue Value: 7 Titles: – TitleFull: Medical mycology Type: main |
| ResultId | 1 |